Trends in the Treatment of Stage III Sacral Pressure Ulcers

In a recent micro survey hosted by 3S Consulting Group and featured within the WOC Skin Health Weekly™ e-newsletter, respondents were asked to report trends in the treatment of Stage III Sacral Pressure Ulcers.

“Stage III SACRAL Pressure Ulcers” defined as full thickness tissue loss; subcutaneous fat may be visible however, bone, tendon, or muscle are not exposed; slough may be present but does not obscure the depth of tissue loss; may include undermining and tunneling.*

Approximately 96% of respondents reported that they routinely treat Stage III Sacral Pressure Ulcers.

Of those that do, 65% described their clinical certification as Wound Ostomy Continence Nurse.  The average years of experience in treating Stage III Sacral Pressure Ulcers ranges between 5-15 years. The Hospital (53%) is the clinical setting in which Stage III Sacral Pressure Ulcers are treated most often, followed by Wound Clinic (16%) and Long Term Care (15%).

When debridement is indicated, Enzymatic (44%) is selected most often for Stage III Sacral Pressure Ulcers, followed by Sharps (surgical) (30%) and Autolytic (23%).

type of debridement

In a recent micro survey hosted by 3S Consulting Group and featured within the WOC Skin Health Weekly™ e-newsletter, respondents were asked to report trends in the treatment of Stage III Sacral Pressure Ulcers.

“Stage III SACRAL Pressure Ulcers” defined as full thickness tissue loss; subcutaneous fat may be visible however, bone, tendon, or muscle are not exposed; slough may be present but does not obscure the depth of tissue loss; may include undermining and tunneling.*

Approximately 96% of respondents reported that they routinely treat Stage III Sacral Pressure Ulcers.

Of those that do, 65% described their clinical certification as Wound Ostomy Continence Nurse.  The average years of experience in treating Stage III Sacral Pressure Ulcers ranges between 5-15 years. The Hospital (53%) is the clinical setting in which Stage III Sacral Pressure Ulcers are treated most often, followed by Wound Clinic (16%) and Long Term Care (15%).

When debridement is indicated, Enzymatic (44%) is selected most often for Stage III Sacral Pressure Ulcers, followed by Sharps (surgical) (30%) and Autolytic (23%).

type of debridement

type of debridement

Those who selected Alginates/Hydrofibers as the primary dressing, reported the reason for selection as “Amount of exudate absorbed” (61%), “Ease of use” (14%), and “Positive patient outcomes” (11%) most often.

Please contact your 3S Account Executive if you are interested in more in-depth research on Trends in the Treatment of Stage III Sacral Pressure Ulcers.